Instil Bio, Inc.
TIL · NASDAQ
Bulios Fair Price
$8.53
20.3% upside
Current Price
$7.09
According to Bulios Fair Price, TIL is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Instil Bio, Inc. is a U.S.-based biotechnology company headquartered in Massachusetts, specializing in the development and production of advanced immunotherapies for cancer treatment. The company utilizes cutting-edge T-cell modification technologies to enhance the efficacy of immunotherapy and improve treatment outcomes for patients with various types of cancer. Instil Bio collaborates with academic and industrial partners and focuses on developing innovative and personalized approaches in the field of oncology immunotherapy.
Sector
Healthcare
Industry
Biotechnology
CEO
Bronson Crouch
Employees
17
Headquarters
Dallas
Upcoming events
Earnings
Upcoming earnings report